APPLICATION
NDA020476
TYPE
NDA
ORIGINAL APPROVAL
1995-05-25
LATEST ACTION
2002-02-04
ROUTE
ORAL
DOSAGE FORM
SUSPENSION/DROPS
MARKETING STATUS
Discontinued
Products
MOTRINDiscontinued
IBUPROFEN 40MG/ML · SUSPENSION/DROPS · ORAL
Approval history
2001-05-14Manufacturing (CMC) · Supplement 3 · standardAP
1995-05-25Type 3 - New Dosage Form · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.